Loading clinical trials...
Loading clinical trials...
Cerebral Amyloid Angiopathy (CAA) is a condition caused by the build-up of a protein called amyloid, predominantly Aβ40, within the walls of brain blood vessels, especially those blood vessels in the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT05709314 · Cerebral Amyloid Angiopathy
NCT07026994 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
NCT05734378 · Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, and more
NCT05394636 · Cerebral Amyloid Angiopathy, Siderosis
NCT05499169 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage, and more
UCLA Ronald Reagan Medical Center
Los Angeles, California
MGH Stroke Research Center
Boston, Massachusetts
Boston Medical Center - Menino Pavilion
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions